Pyrazoline Containing Compounds as Therapeutic Targets for Neurodegenerative Disorders

Pharmacology, Toxicology and Pharmaceutical Science

• Degenerative Disease 100%
• Acetylcholinesterase 100%
• Alzheimer's Disease 66%
• Parkinson's Disease 66%
• Biological Activity 33%
• Molecular Docking Simulations 33%
• Neuroprotective Agent 33%
• Structure Activity Relationship 33%
• Amyloid Protein 33%
• Heterocyclic Compound 33%
• Pharmacological Activity 33%
• Cholinesterase Inhibitor 33%

Medicine and Dentistry

• Acetylcholinesterase 100%
• Biological Functions 33%
• Structure-Activity Relationship 33%
• Heterocyclic Compound 33%
• Neuroprotective Agent 33%
• Amyloid Beta 33%
• Acetylcholinesterase Inhibitor 33%
• Mental Disorder 33%
• Amine Oxidase (Flavin Containing) 33%
• Biological Activity 33%